Eleven Biotherapeutics, Inc. EBIO was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 134% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.Eleven Biotherapeutics currently carries a Zacks Rank #3 (Hold).
ELEVEN BIOTHERP Price
ELEVEN BIOTHERP Price | ELEVEN BIOTHERP Quote
A better-ranked stock in the same industry is ANI Pharmaceuticals, Inc. ANIP, sporting a Zacks Rank #1 (Strong Buy).
Is EBIO going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ELEVEN BIOTHERP (EBIO): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research